Insufficient scRNA-seq data for expression of OSTN at single-cell level.
Insufficient scRNA-seq data for expression of OSTN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 77% | 50.56 | 2023 / 2642 | 18% | 0.89 | 125 / 705 |
muscle | 73% | 39.80 | 583 / 803 | 0% | 0 | 0 / 0 |
bladder | 71% | 47.90 | 15 / 21 | 1% | 0.07 | 4 / 504 |
heart | 64% | 16.16 | 553 / 861 | 0% | 0 | 0 / 0 |
breast | 61% | 16.17 | 278 / 459 | 0% | 0.02 | 4 / 1118 |
lung | 60% | 12.79 | 344 / 578 | 1% | 0.04 | 16 / 1155 |
skin | 56% | 17.18 | 1017 / 1809 | 2% | 1.44 | 11 / 472 |
ovary | 49% | 11.69 | 89 / 180 | 5% | 2.53 | 23 / 430 |
spleen | 52% | 7.96 | 126 / 241 | 0% | 0 | 0 / 0 |
uterus | 44% | 10.26 | 75 / 170 | 7% | 13.01 | 33 / 459 |
thymus | 50% | 9.23 | 326 / 653 | 1% | 0.02 | 5 / 605 |
intestine | 49% | 9.49 | 478 / 966 | 0% | 0 | 0 / 527 |
adipose | 49% | 9.62 | 594 / 1204 | 0% | 0 | 0 / 0 |
kidney | 46% | 6.93 | 41 / 89 | 2% | 0.03 | 15 / 901 |
prostate | 38% | 17.27 | 92 / 245 | 4% | 0.34 | 18 / 502 |
blood vessel | 33% | 7.61 | 444 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 19% | 2.11 | 269 / 1445 | 1% | 0.01 | 1 / 183 |
adrenal gland | 18% | 1.88 | 46 / 258 | 0% | 0 | 0 / 230 |
stomach | 14% | 3.03 | 51 / 359 | 1% | 0.05 | 2 / 286 |
pancreas | 8% | 0.73 | 27 / 328 | 1% | 0.01 | 1 / 178 |
liver | 6% | 0.66 | 13 / 226 | 0% | 0.11 | 2 / 406 |
peripheral blood | 4% | 0.51 | 37 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_1903860 | Biological process | negative regulation of dendrite extension |
GO_0030154 | Biological process | cell differentiation |
GO_0003416 | Biological process | endochondral bone growth |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005179 | Molecular function | hormone activity |
GO_0005102 | Molecular function | signaling receptor binding |
Gene name | OSTN |
Protein name | Osteocrin Osteocrin (Musclin) [Cleaved into: Processed Osteocrin] |
Synonyms | |
Description | FUNCTION: Hormone that acts as a regulator of dendritic growth in the developing cerebral cortex in response to sensory experience . Induced in the brain following membrane depolarization and inhibits dendritic branching in neurons of the developing cortex . Probably acts by binding to natriuretic peptide receptor NPR3/NPR-C, thereby preventing binding between NPR3/NPR-C and natriuretic peptides, leading to increase cGMP production (By similarity). . |
Accessions | ENST00000445281.5 ENST00000682035.1 P61366 C9JER6 |